SKP2 and prostate carcinoma: For example, S-phase kinase associated protein-2 (SKP2) was shown to increase the level of H3K4me3 through decreasing the K63-linked ubiquitination of KDM5B by E3 ubiquitin ligase TRAF6 in prostate cancer cells [31].